MCID: SPR012
MIFTS: 34

Separation Anxiety Disorder malady

Category: Mental diseases

Aliases & Classifications for Separation Anxiety Disorder

About this section

Aliases & Descriptions for Separation Anxiety Disorder:

Name: Separation Anxiety Disorder 11 13 67
 
Separation Anxiety Disorder of Childhood 67

Classifications:



External Ids:

Disease Ontology11 DOID:10685

Summaries for Separation Anxiety Disorder

About this section
Disease Ontology:11 An anxiety disorder that involves the feeling of excessive and inappropriate levels of anxiety over being separated from a person to whom the individual has a strong emotional attachment or place.

MalaCards based summary: Separation Anxiety Disorder, also known as separation anxiety disorder of childhood, is related to anxiety disorder and adult spinal cord ependymoma, and has symptoms including child behavior symptom/complaint An important gene associated with Separation Anxiety Disorder is DRD4 (Dopamine Receptor D4), and among its related pathways is Antigen Presentation- Folding, assembly and peptide loading of class I MHC. Affiliated tissues include brain, lung and bone, and related mouse phenotypes are behavior/neurological and nervous system.

Wikipedia:70 Separation anxiety disorder (SepAD), is an anxiety disorder in which an individual experiences excessive... more...

Related Diseases for Separation Anxiety Disorder

About this section

Diseases related to Separation Anxiety Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 36)
idRelated DiseaseScoreTop Affiliating Genes
1anxiety disorder11.3
2adult spinal cord ependymoma10.5DRD4, HLA-A
3branch retinal artery occlusion10.4HLA-A, HLA-B
4progressive locomotor ataxia10.4HLA-A, HLA-B
5gonococcal iridocyclitis10.4HLA-A, HLA-B
6mitochondrial encephalomyopathy10.3HLA-A, HLA-B
7glucose intolerance10.3DRD4, HTR7
8antigen-peptide-transporter 2 deficiency10.3HLA-A, HLA-B
9hypercementosis10.3HLA-A, HLA-B
10chronic cervicitis10.3DRD4, PRL, SLC6A3
11acinar cell carcinoma10.3DRD4, PRL, SLC6A3
12thrombotic thrombocytopenic purpura10.2HLA-A, HLA-B
13human herpesvirus 810.2HLA-A, HLA-B
14potato nose10.2HLA-A, HLA-B
15panic disorder10.1
16foster-kennedy syndrome10.1HLA-A, HLA-B
17glutathionuria10.0CORT, HTR7, SLC6A3
18measles10.0CORT, HTR7, SLC6A3
19lipodermatosclerosis9.9HLA-A, HLA-B
20social phobia9.9
21agoraphobia9.9
22aicardi-goutieres syndrome 29.9DRD4, OXT, PRL, SLC6A3
23generalized anxiety disorder9.8
24personality disorder9.8
25diffuse interstitial keratitis9.8OXT, PRL, RTN4
26aphasia9.7OXT, PRL, RTN4
27enthesopathy9.7DRD4, OXT, PRL, SLC6A3, TSPO
28obsessive-compulsive disorder9.7
29phobia, specific9.7
30oppositional defiant disorder9.7
31autism spectrum disorder9.7
32dependent personality disorder9.7
33mood disorder9.7
34pervasive developmental disorder9.5DRD4, HTR7, OXT, RTN4, SLC6A3
35avoidant personality disorder9.2DRD4, HTR7, OXT, PRL, RTN4, SLC6A3
36hypertrophy of breast5.8ADAD2, CORT, DRD4, EPRS, GTF2I, HLA-A

Graphical network of the top 20 diseases related to Separation Anxiety Disorder:



Diseases related to separation anxiety disorder

Symptoms for Separation Anxiety Disorder

About this section

UMLS symptoms related to Separation Anxiety Disorder:


child behavior symptom/complaint

Drugs & Therapeutics for Separation Anxiety Disorder

About this section

Drugs for Separation Anxiety Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 99)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CitalopramapprovedPhase 4, Phase 150359729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
2
Midazolamapproved, illicitPhase 4, Phase 3, Phase 268459467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
3
SertralineapprovedPhase 4, Phase 329579617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
4
Gabapentinapproved, investigationalPhase 428960142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
5
Ketamineapproved, vet_approvedPhase 45286740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
 
DL-ketamine
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine [INN:BAN]
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
Special k
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
6
Dexmedetomidineapproved, vet_approvedPhase 454076631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
7
Sevofluraneapproved, vet_approvedPhase 447928523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
8
Alfentanilapproved, illicitPhase 43671195-58-951263
Synonyms:
5-26-13-00110 (Beilstein Handbook Reference)
70879-28-6 (hydrochloride)
71195-58-9
AC1L1ARM
AC1Q6F0S
ALFENTANIL
Alfenta
Alfentanil (INN)
Alfentanil [INN:BAN]
Alfentanilum
Alfentanilum [INN-Latin]
Alfentanyl
BRN 1188293
C08005
CHEBI:127190
CHEBI:2569
 
CHEMBL634
CID51263
D07122
DB00802
DEA No. 9737
HSDB 6789
L001231
LS-119259
MolPort-004-285-887
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)-N-phenylpropionamid
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilid
N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide
N-[1-[2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide
N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-[(methyloxy)methyl]piperidin-4-yl}-N-phenylpropanamide
Rapifen (TN)
UNII-1N74HM2BS7
9
Lidocaineapproved, vet_approvedPhase 41226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
10
Epinephrineapproved, vet_approvedPhase 493351-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
11
VortioxetineapprovedPhase 462508233-74-79966051
Synonyms:
4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium
 
BRINTELLIX
vortioxetine cation
12Hypnotics and SedativesPhase 4, Phase 3, Phase 22485
13GABA AgentsPhase 4, Phase 3, Phase 21622
14GABA ModulatorsPhase 4, Phase 3, Phase 2864
15Tranquilizing AgentsPhase 4, Phase 3, Phase 24164
16Antiparkinson AgentsPhase 4, Phase 11527
17Antidepressive AgentsPhase 4, Phase 3, Phase 12666
18Anti-Anxiety AgentsPhase 4, Phase 3, Phase 21816
19Peripheral Nervous System AgentsPhase 4, Phase 122776
20Central Nervous System DepressantsPhase 4, Phase 3, Phase 212806
21Serotonin AgentsPhase 4, Phase 3, Phase 13102
22Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 11570
23Adjuvants, AnesthesiaPhase 4, Phase 3, Phase 21588
24
SerotoninPhase 4, Phase 3, Phase 1356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
25Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 16279
26Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 117734
27Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 2, Phase 13464
28Muscarinic AntagonistsPhase 4, Phase 11134
29ParasympatholyticsPhase 4, Phase 11050
30Cholinergic AntagonistsPhase 4, Phase 11658
31Anesthetics, GeneralPhase 4, Phase 3, Phase 22787
32Anesthetics, IntravenousPhase 4, Phase 3, Phase 22406
33AnestheticsPhase 4, Phase 3, Phase 29001
34Antidepressive Agents, Second-GenerationPhase 4, Phase 3, Phase 11287
35Cholinergic AgentsPhase 4, Phase 13846
36Autonomic AgentsPhase 4, Phase 19774
37NarcoticsPhase 43486
38Platelet Aggregation InhibitorsPhase 42419
39Antimanic AgentsPhase 4790
40
gamma-Aminobutyric AcidPhase 423056-12-2119
Synonyms:
3-Carboxypropylamine
4-Aminobutanoate
4-Aminobutanoic acid
4-Aminobutyrate
4-Aminobutyric acid
Aminalon
GABA
Gaballon
Gamarex
Gammalon
Gammalone
Gammar
Gammasol
 
Mielogen
Mielomade
Omega-Aminobutyrate
Omega-Aminobutyric acid
Piperidate
Piperidic acid
Piperidinate
Piperidinic acid
gamma Aminobutyrate
gamma Aminobutyric acid
gamma-Aminobutyrate
gamma-Aminobutyric acid
w-Aminobutyrate
w-Aminobutyric acid
41calcium channel blockersPhase 41940
42AnticonvulsantsPhase 42620
43Calcium, DietaryPhase 45525
44Adrenergic alpha-AgonistsPhase 4, Phase 21625
45AnalgesicsPhase 411287
46Analgesics, Non-NarcoticPhase 46260
47Adrenergic alpha-2 Receptor AgonistsPhase 4, Phase 2911
48Adrenergic AgonistsPhase 4, Phase 22877
49Anesthetics, InhalationPhase 4649
50Adrenergic AgentsPhase 4, Phase 25140

Interventional clinical trials:

(show top 50)    (show all 71)
idNameStatusNCT IDPhase
1Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and AdolescentsCompletedNCT01160588Phase 4
2Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric PatientsCompletedNCT02072083Phase 4
3The Effect of Parental Presence on Dental FearCompletedNCT02619981Phase 4
4Sevoflurane Induced Emergence AgitationCompletedNCT02022488Phase 4
5Plasma Gabapentin Concentration During and Following Cardiac BypassCompletedNCT01022736Phase 4
6A Comparison of Two Doses of Intranasal Dexmedetomidine for Premedication in ChildrenRecruitingNCT02459509Phase 4
7Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of VortioxetineRecruitingNCT02969876Phase 4
8Vilazodone for Separation Anxiety DisorderActive, not recruitingNCT01999920Phase 4
9Developing New Clinical Management StrategiesActive, not recruitingNCT02082392Phase 4
10Child and Adolescent Anxiety Disorders (CAMS)Unknown statusNCT00052078Phase 3
11Sedation in the Intensive Care UnitUnknown statusNCT00221520Phase 3
12Treatment for Anxiety in ChildrenCompletedNCT00000389Phase 3
13Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health CentersCompletedNCT01416805Phase 3
14Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01178385Phase 2, Phase 3
15A Study of Pediatric Patients With Attention Deficit/Hyperactivity DisorderCompletedNCT00922636Phase 2, Phase 3
16Reduction of Preoperative Anxiety in Children: Electronic Tab vs MidazolamCompletedNCT02192710Phase 3
17Study to See if Microcoil Insertion Reduces the Rate of Open Thoracotomy for Removal of Lung NodulesCompletedNCT01028417Phase 3
18Psychotherapy for Anxiety in Children With Autism Spectrum DisorderRecruitingNCT02028247Phase 3
19A Comparison of Midazolam and Zolpidem as Oral Premedication in ChildrenActive, not recruitingNCT02096900Phase 3
20Treatment Study for Rural Latino Youth With AnxietyUnknown statusNCT01491880Phase 1, Phase 2
21SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)CompletedNCT01470469Phase 2
22Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School SettingsCompletedNCT00569829Phase 2
23Effects of Parental Behavior on Child Anxiety RegulationCompletedNCT00593515Phase 2
24Effectiveness Study of CBT for Anxiety in ChildrenCompletedNCT00586586Phase 2
25Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in NorwayCompletedNCT00735995Phase 2
26A GameBoy as a Distraction Before Surgery in ChildrenCompletedNCT00176670Phase 2
27Brief Behavioral Treatment for Anxiety in Young ChildrenCompletedNCT02051192Phase 1, Phase 2
28Cipralex® for Anxiety Disorders in AdolescentsUnknown statusNCT01293838Phase 1
29A Research Study of How Teens With and Without an Anxiety Disorder Make DecisionsCompletedNCT00104195Phase 1
30G-CSF to Treat Crohn's DiseaseCompletedNCT00025805Phase 1
31Youth Mayo Clinic Anxiety Coach Randomized Controlled TrialNot yet recruitingNCT02205203Phase 1
32Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in ChildrenUnknown statusNCT01687764
33Comorbidity Between Balance and Childhood AnxietyUnknown statusNCT00599742
34Effectiveness of Music TherapyUnknown statusNCT01040611
35Assessing Different Methods of Anxiety Care in Pediatric SettingsUnknown statusNCT00769925
36TAFF-Psychological Treatment of Separation Anxiety DisorderCompletedNCT00255112
37Cartoon Distraction and Parental Presence on Anxiety in Pediatric AnesthesiaCompletedNCT02027844
38Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical SettingCompletedNCT02306356
39Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment StudyCompletedNCT00774150
40Sleep, Mood, and Behavior StudyCompletedNCT00787397
41Treatment of Youth With ADHD and AnxietyCompletedNCT00012584
42Internet-delivered Cognitive Behavior Therapy (CBT) for Children Age 8-12 Years With Anxiety DisordersCompletedNCT01533402
43Ventilatory Physiology in Children at Risk for AnxietyCompletedNCT00101777
44Reward-Related Processes and Brain FunctionCompletedNCT00029588
45Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01565629
46Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With AutismCompletedNCT01563003
47CO2 Inhalation and Risk for Panic DisorderCompletedNCT00930657
48Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and Mother-child RelationshipsCompletedNCT01566058
49Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)RecruitingNCT02310152
50Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and SleepRecruitingNCT02189213

Search NIH Clinical Center for Separation Anxiety Disorder

Genetic Tests for Separation Anxiety Disorder

About this section

Anatomical Context for Separation Anxiety Disorder

About this section

MalaCards organs/tissues related to Separation Anxiety Disorder:

35
Brain, Lung, Bone, Eye

Animal Models for Separation Anxiety Disorder or affiliated genes

About this section

MGI Mouse Phenotypes related to Separation Anxiety Disorder:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053867.6CORT, DRD4, GTF2I, HTR7, LTBP3, MB21D1
2MP:00036316.7DRD4, EPRS, GTF2I, HTR7, OXT, PHGDH

Publications for Separation Anxiety Disorder

About this section

Articles related to Separation Anxiety Disorder:

(show top 50)    (show all 86)
idTitleAuthorsYear
1
Adult separation anxiety disorder in complicated grief: an exploratory study on frequency and correlates. (27683967)
2017
2
Associations of adult separation anxiety disorder with conflict-related trauma, ongoing adversity, and the psychosocial disruptions of mass conflict among West Papuan refugees. (26752442)
2016
3
Can separation anxiety disorder escape its attachment to childhood? (27265693)
2016
4
Why are we still missing adult separation anxiety disorder in clinical practice? (27343899)
2016
5
Separation anxiety disorder from the perspective of DSM-5: clinical investigation among subjects with panic disorder and associations with mood disorders spectrum. (25704393)
2015
6
Dependent personality, separation anxiety disorder and other anxiety disorders in OCD. (26542617)
2015
7
Pediatric-Onset and Adult-Onset Separation Anxiety Disorder Across Countries in the World Mental Health Survey. (26046337)
2015
8
Separation anxiety disorder in adult patients with obsessive-compulsive disorder: Prevalence and clinical correlates. (24908152)
2014
9
The right amygdalar tumor presenting with symptoms of separation anxiety disorder (SAD): a case report. (24593853)
2014
10
The effective comparison between emotion-focused cognitive behavioral group therapy and cognitive behavioral group therapy in children with separation anxiety disorder. (24949029)
2014
11
Early-life risk factors for panic and separation anxiety disorder: Insights and outstanding questions arising from human and animal studies of CO2 sensitivity. (24793177)
2014
12
The relationships among separation anxiety disorder, adult attachment style and agoraphobia in patients with panic disorder. (25218272)
2014
13
Let's not abandon separation anxiety disorder in adulthood. (23901150)
2013
14
The efficacy of a family-based cognitive-behavioral treatment for separation anxiety disorder in children aged 8-13: a randomized comparison with a general anxiety program. (23607501)
2013
15
Looking for balance between promoting adult separation anxiety disorder and overlooking it. (23901151)
2013
16
The Diagnostic Utility of Separation Anxiety Disorder Symptoms: An Item Response Theory Analysis. (23963543)
2013
17
Overlap of symptom domains of separation anxiety disorder in adulthood with panic disorder-agoraphobia. (23247205)
2013
18
Beliefs regarding child anxiety and parenting competence in parents of children with separation anxiety disorder. (22922077)
2013
19
A randomized controlled trial of the child anxiety multi-day program (cAMP) for separation anxiety disorder. (23053618)
2013
20
Adult separation anxiety disorder in DSM-5. (23673209)
2013
21
Separation anxiety disorder increases among neonatal intensive care unit graduates. (21819341)
2012
22
Childhood separation anxiety disorder and adult onset panic attacks share a common genetic diathesis. (22461084)
2012
23
The relationship between adult separation anxiety disorder and complicated grief in a cohort of 454 outpatients with mood and anxiety disorders. (22832169)
2012
24
Does the vigilance-avoidance gazing behavior of children with separation anxiety disorder change after cognitive-behavioral therapy? (22466517)
2012
25
Hypersensitivity to 35% carbon dioxide in patients with adult separation anxiety disorder. (22542862)
2012
26
Separation anxiety disorder in OCD. (21308883)
2011
27
Disorder-specific cognitive-behavioral therapy for separation anxiety disorder in young children: a randomized waiting-list-controlled trial. (21494062)
2011
28
Children suffering from separation anxiety disorder (SAD) show increased HPA axis activity compared to healthy controls. (20870248)
2011
29
Development and Preliminary Evaluation of a 1-Week Summer Treatment Program for Separation Anxiety Disorder. (21935300)
2009
30
Adult attachment styles in panic disorder with and without comorbid adult separation anxiety disorder. (19153925)
2009
31
SEPARATION ANXIETY DISORDER IN YOUTH: PHENOMENOLOGY, ASSESSMENT, AND TREATMENT. (19966943)
2008
32
The unique impact of parent training for separation anxiety disorder in children. (18502252)
2008
33
Separation anxiety disorder in childhood as a risk factor for future mental illness. (18356763)
2008
34
Separation anxiety disorder in a 13-year-old boy managed by the Neuro Emotional Technique as a biopsychosocial intervention. (19646371)
2008
35
Separation anxiety disorder and school refusal in childhood: potential risk factors for developing distinct psychiatric disorders? (18311428)
2008
36
Separation anxiety disorder and school refusal in children and adolescents. (16452275)
2006
37
Separation anxiety disorder. (15768687)
2005
38
Asperger's disorder with co-morbid separation anxiety disorder: a case report. (15796129)
2005
39
Risk for separation anxiety disorder among girls: paternal absence, socioeconomic disadvantage, and genetic vulnerability. (15122944)
2004
40
Informant disagreement for separation anxiety disorder. (15187805)
2004
41
Comorbidity of dependent personality disorder and separation anxiety disorder in addictive disorders and in healthy subjects. (12239442)
2002
42
Relationship between separation anxiety disorder, parental panic disorder, and atopic disorders in children: a controlled high-risk study. (12162630)
2002
43
Associations between juvenile and adult forms of separation anxiety disorder: a study of adult volunteers with histories of school refusal. (12080215)
2002
44
Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management. (11460893)
2001
45
Dysfunctional cognitions in children with social phobia, separation anxiety disorder, and generalized anxiety disorder. (10834771)
2000
46
Separation anxiety disorder: planning treatment. (10878189)
2000
47
School phobia with separation anxiety disorder: a comparative 20- to 29-year follow-up study of 35 school refusers. (8980867)
1997
48
Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. (7653694)
1995
49
Childhood separation anxiety disorder in patients with adult anxiety disorders. (8185008)
1994
50
Behavior therapy for separation anxiety disorder. (3069093)
1988

Variations for Separation Anxiety Disorder

About this section

Expression for genes affiliated with Separation Anxiety Disorder

About this section
Search GEO for disease gene expression data for Separation Anxiety Disorder.

Pathways for genes affiliated with Separation Anxiety Disorder

About this section

Pathways related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.9HLA-A, HLA-B

GO Terms for genes affiliated with Separation Anxiety Disorder

About this section

Cellular components related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class I protein complexGO:00426129.9HLA-A, HLA-B

Biological processes related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of penile erectionGO:006040610.3DRD4, OXT
2antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:000248010.3HLA-A, HLA-B
3regulation of dopamine metabolic processGO:004205310.1DRD4, SLC6A3
4chemical synaptic transmissionGO:00072688.7CORT, HTR7, PTPRF, TSPO

Molecular functions related to Separation Anxiety Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dopamine bindingGO:003524010.1DRD4, SLC6A3

Sources for Separation Anxiety Disorder

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet